Heterogeneous characterization of neutrophilic cells in head and neck cancers.
By: Magdalena Fay, Paul E Clavijo, Clint T Allen

Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
2024-3-14; doi: 10.1002/hed.27774
Abstract

Background

Neutrophilic cells are among the most abundant immune populations within the head and neck tumor microenvironment (TME) and harbor multiple mechanisms of immunosuppression. Despite these important features, neutrophilic cells may be underrepresented in contemporary studies that aim to comprehensively characterize the immune landscape of the TME due to discrepancies in tissue processing and analysis techniques. Here, we review the role of pathologically activated neutrophilic cells within the TME and pitfalls of various approaches used to study their frequency and function in clinical samples.

Methods

The literature was identified by searching PubMed for "immune landscape" and "tumor immune microenvironment" in combination with keywords describing solid tumor malignancies. Key publications that assessed the immune composition of solid tumors derived from human specimens were included. The tumor and blood processing methodologies in each study were reviewed in depth and correlated with the reported abundance of neutrophilic cells.

Results

Neutrophilic cells do not survive cryopreservation, and many studies fail to identify and study neutrophilic cell populations due to cryopreservation of clinical samples for practical reasons. Additional single-cell transcriptomic studies filter out neutrophilic cells due to low transcriptional counts.

Conclusions

This report can help readers critically interpret studies aiming to comprehensively study the immune TME that fail to identify and characterize neutrophilic cells.



© 2024 The Authors. Head & Neck published by Wiley Periodicals LLC.

PMID:38622975






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements